| 臺大學術典藏 |
2021-03-11T07:58:39Z |
Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion
|
Lee L.-N.; Luh K.-T.; Yang P.-C.; Chang D.-B.; Yu C.-J.; JEN-CHANG KO; Liaw Y.-S.; Wu R.-G. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
Disseminated coccidioidomycosis [8]
|
Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
Disseminated coccidioidomycosis [8]
|
Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia
|
Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia
|
Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation
|
Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells
|
JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko;Tsai M.-S.;Kuo Y.-H.;Chiu Y.-F.;Weng S.-H.;Su Y.-C.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko;Tsai M.-S.;Kuo Y.-H.;Chiu Y.-F.;Weng S.-H.;Su Y.-C.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Chiu Y.-F. ;Weng S.-H. ;Kuo Y.-H. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Chiu Y.-F. ;Weng S.-H. ;Kuo Y.-H. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:35Z |
Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells
|
JEN-CHANG KO; Huang Y.-C.; Chen H.-J.; Tseng S.-C.; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Weng S.-H.; Chiou R.Y.Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:35Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Weng S.-H. ;Kuo Y.-H. ;Chiu Y.-F. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:35Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Weng S.-H. ;Kuo Y.-H. ;Chiu Y.-F. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:35Z |
HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
|
JEN-CHANG KO; Chen H.-J.; Huang Y.-C.; Tseng S.-C.; Weng S.-H.; Wo T.-Y.; Huang Y.-J.; Chiu H.-C.; Tsai M.-S.; Chiou R.Y.Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:34Z |
Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012
|
Lee M.-R.; Wang H.-C.; Yang C.-Y.; Lin C.-K.; Kuo H.-Y.; JEN-CHANG KO; Sheng W.-H.; Lee L.-N.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-03-11T07:58:34Z |
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells
|
Chen R.-S.; JEN-CHANG KO; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Chen H.-J.; Huang Y.-C.; Jian Y.-J.; Lee W.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:34Z |
Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Huang Y.-C.; Chen H.-J.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Jian Y.-J.; Chang P.-Y.; Wang T.-J.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination
|
Lee M.-R.; Yang C.-Y.; Shu C.-C.; Lin C.-K.; Wen Y.-F.; Lee S.-W.; JEN-CHANG KO; Wang J.-Y.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-03-11T07:58:32Z |
Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells
|
JEN-CHANG KO; Chen J.-C.; Wang T.-J.; Zheng H.-Y.; Chen W.-C.; Chang P.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:32Z |
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
|
JEN-CHANG KO; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:32Z |
Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells
|
JEN-CHANG KO; Wang T.-J.; Chang P.-Y.; Syu J.-J.; Chen J.-C.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Zheng H.-Y.; Chen W.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:32Z |
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities
|
Lee M.-R.; Tsai C.-J.; Hu J.-Y.; Lee S.-W.; JEN-CHANG KO; Wang H.-C.; Yu C.-J.; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-03-11T07:58:31Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T07:58:31Z |
Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression
|
JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:31Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; Liang S.-K.; Liang M.-C. |
| 臺大學術典藏 |
2021-03-11T07:58:30Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
Lee M.-R.; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; JEN-CHANG KO; Yu C.-J.; Lin H.-H. |
| 臺大學術典藏 |
2021-03-11T07:58:30Z |
Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan
|
Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T07:58:29Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T07:58:29Z |
Cementing an unwanted relationship
|
Chang C.-H.; Keng L.-T.; JEN-CHANG KO |
| 臺大學術典藏 |
2021-03-11T07:58:29Z |
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
|
Lee M.-R.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Chang L.-Y.; Yu K.-L.; JEN-CHANG KO; Wang J.-Y.; Wang J.-T.; Lee L.-N. |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells
|
Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C. |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T07:58:27Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y. |
| 臺大學術典藏 |
2021-03-11T07:58:27Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y. |
